Health ❯ Medicine ❯ Neurology

Epilepsy

Seizure Reduction Treatment-Resistant Epilepsy SCN8A Gene Variants Developmental and Epileptic Encephalopathies Treatment Methods Post-ictal Symptoms Deep Brain Stimulation

Praxis Relutrigine Study Halted Early for Efficacy as FDA Review Meeting Set

The readout advances a potential first targeted therapy for severe SCN2A and SCN8A epilepsies.